JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M108931200 on October 24, 2001

J. Biol. Chem., Vol. 277, Issue 1, 187-193, January 4, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/1/187    most recent
M108931200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kao, H.-Y.
Right arrow Articles by Evans, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kao, H.-Y.
Right arrow Articles by Evans, R. M.

Isolation and Characterization of Mammalian HDAC10, a Novel Histone Deacetylase*

Hung-Ying KaoDagger §, Chih-Hao Lee, Andrei KomarovDagger , Chris C. HanDagger , and Ronald M. Evans||

From the Dagger  Department of Biochemistry, School of Medicine, Case Western Reserve University (CWRU), the Research Institute of University Hospitals of Cleveland (UHC), and the Comprehensive Cancer Center of CWRU and UHC, Cleveland, Ohio 44106 and the  Howard Hughes Medical Institute, Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037

Acetylation of histone core particles plays an important role in modulating chromatin structure and gene expression. The acetylation status of the histone tails is determined by two opposing enzymatic activities, histone acetyltransferases and histone deacetylases (HDACs). Here we describe the isolation and characterization of HDAC10, a novel class II histone deacetylase. Molecular cloning and Northern blot analyses reveal that the HDAC10 transcript is widely expressed and subjected to alternative splicing. HDAC10 is both nuclear and cytoplasmic, a feature reminiscent of HDACs 4, 5, and 7. Distinct from other family members, HDAC10 harbors an amino-terminal catalytic domain and a carboxyl pseudo-repeat that shares significant homology with its catalytic domain. Mutational analysis reveals that transcriptional repression by HDAC10 requires its intrinsic histone deacetylase activity. Taken together, HDAC10 represents a distinct HDAC that may play a role in transcription regulation.

* This work was supported by a start-up fund (to H. Y. K.) and National Institutes of Health Grant HD27183 (to R. M. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF407272 (HDAC10alpha ) and AF407273 (HDAC10beta ).

§ Recipient of the James T. Pardee-Carl A. Gerstacker Assistant Professor of Cancer Research Faculty, and Chair in Cancer Research at CWRU Cancer Center. To whom correspondence may be addressed: Dept. of Biochemistry, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106. Tel.: 216-844-7572; Fax: 216-368-3419; E-mail: hxk43@po.cwru.edu.

|| Investigator of the Howard Hughes Medical Institute at the Salk Institute for Biological Studies, and March of Dimes Chair in Molecular and Developmental Biology. To whom correspondence may be addressed: The Howard Hughes Medical Institute, Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010 Torrey Pines Rd., La Jolla, CA 92037. Tel.: 858-453-4100, Ext. 1585; Fax: 858-455-1349; E-mail: evans@salk.edu.

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
M. Fournel, C. Bonfils, Y. Hou, P. T. Yan, M.-C. Trachy-Bourget, A. Kalita, J. Liu, A.-H. Lu, N. Z. Zhou, M.-F. Robert, et al.
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
Mol. Cancer Ther., April 1, 2008; 7(4): 759 - 768.
[Abstract] [Full Text] [PDF]

Home page
 Brief Funct Genomic ProteomicHome page
H. Fukuda, N. Sano, S. Muto, and M. Horikoshi
Simple histone acetylation plays a complex role in the regulation of gene expression.
Brief Funct Genomic Proteomic, September 1, 2006; 5(3): 190 - 208.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Xu, P. K. Sengupta, E. Seto, and B. D. Smith
Regulatory Factor for X-box Family Proteins Differentially Interact with Histone Deacetylases to Repress Collagen {alpha}2(I) Gene (COL1A2) Expression
J. Biol. Chem., April 7, 2006; 281(14): 9260 - 9270.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. J. Yoo, J.-J. Chung, S. S. Choe, K. H. Kim, and J. B. Kim
Down-regulation of Histone Deacetylases Stimulates Adipocyte Differentiation
J. Biol. Chem., March 10, 2006; 281(10): 6608 - 6615.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. K. Mukhopadhyay, E. Weisberg, D. Gilchrist, R. Bueno, D. J. Sugarbaker, and M. T. Jaklitsch
Effectiveness of Trichostatin A as a Potential Candidate for Anticancer Therapy in Non-Small-Cell Lung Cancer.
Ann. Thorac. Surg., March 1, 2006; 81(3): 1034 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
X.-J. Yang and S. Gregoire
Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication
Mol. Cell. Biol., April 15, 2005; 25(8): 2873 - 2884.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Waltregny, L. de Leval, W. Glenisson, S. Ly Tran, B. J. North, A. Bellahcene, U. Weidle, E. Verdin, and V. Castronovo
Expression of Histone Deacetylase 8, a Class I Histone Deacetylase, Is Restricted to Cells Showing Smooth Muscle Differentiation in Normal Human Tissues
Am. J. Pathol., August 1, 2004; 165(2): 553 - 564.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
E. Hu, E. Dul, C.-M. Sung, Z. Chen, R. Kirkpatrick, G.-F. Zhang, K. Johanson, R. Liu, A. Lago, G. Hofmann, et al.
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 720 - 728.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
J. R. Davie
Inhibition of Histone Deacetylase Activity by Butyrate
J. Nutr., July 1, 2003; 133(7): 2485S - 2493.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Ju and M. T. Muller
Histone Deacetylase Inhibitors Activate p21WAF1 Expression via ATM
Cancer Res., June 1, 2003; 63(11): 2891 - 2897.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
I. Berger, C. Bieniossek, C. Schaffitzel, M. Hassler, E. Santelli, and T. J. Richmond
Direct Interaction of Ca2+/Calmodulin Inhibits Histone Deacetylase 5 Repressor Core Binding to Myocyte Enhancer Factor 2
J. Biol. Chem., May 9, 2003; 278(20): 17625 - 17635.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Petrie, F. Guidez, L. Howell, L. Healy, S. Waxman, M. Greaves, and A. Zelent
The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms
J. Biol. Chem., April 25, 2003; 278(18): 16059 - 16072.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
S. THIAGALINGAM, K.-H. CHENG, H. J. LEE, N. MINEVA, A. THIAGALINGAM, and J. F. PONTE
Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 84 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. De Schepper, H. Bruwiere, T. Verhulst, U. Steller, L. Andries, W. Wouters, M. Janicot, J. Arts, and J. Van heusden
Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin
J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 881 - 888.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
K. B. Glaser, M. J. Staver, J. F. Waring, J. Stender, R. G. Ulrich, and S. K. Davidsen
Gene Expression Profiling of Multiple Histone Deacetylase (HDAC) Inhibitors: Defining a Common Gene Set Produced by HDAC Inhibition in T24 and MDA Carcinoma Cell Lines
Mol. Cancer Ther., February 1, 2003; 2(2): 151 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
Z. Ding, L. L. Gillespie, and G. D. Paterno
Human MI-ER1 Alpha and Beta Function as Transcriptional Repressors by Recruitment of Histone Deacetylase 1 to Their Conserved ELM2 Domain
Mol. Cell. Biol., January 1, 2003; 23(1): 250 - 258.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
J. J. Westendorf, S. K. Zaidi, J. E. Cascino, R. Kahler, A. J. van Wijnen, J. B. Lian, M. Yoshida, G. S. Stein, and X. Li
Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter
Mol. Cell. Biol., November 15, 2002; 22(22): 7982 - 7992.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. M. Butler, X. Zhou, W.-S. Xu, H. I. Scher, R. A. Rifkind, P. A. Marks, and V. M. Richon
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
PNAS, September 3, 2002; 99(18): 11700 - 11705.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Fournel, M.-C. Trachy-Bourget, P. T. Yan, A. Kalita, C. Bonfils, C. Beaulieu, S. Frechette, S. Leit, E. Abou-Khalil, S.-H. Woo, et al.
Sulfonamide Anilides, a Novel Class of Histone Deacetylase Inhibitors, Are Antiproliferative against Human Tumors
Cancer Res., August 1, 2002; 62(15): 4325 - 4330.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. David, M. A. Neptune, and R. A. DePinho
SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities
J. Biol. Chem., June 21, 2002; 277(26): 23658 - 23663.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Lemercier, M.-P. Brocard, F. Puvion-Dutilleul, H.-Y. Kao, O. Albagli, and S. Khochbin
Class II Histone Deacetylases Are Directly Recruited by BCL6 Transcriptional Repressor
J. Biol. Chem., June 7, 2002; 277(24): 22045 - 22052.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. B. Hartman, X. Hu, K. X. Tyler, C. K. Dalal, and M. A. Lazar
Mechanisms Regulating Adipocyte Expression of Resistin
J. Biol. Chem., May 24, 2002; 277(22): 19754 - 19761.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. J. Tong, J. Liu, N. R. Bertos, and X.-J. Yang
Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain
Nucleic Acids Res., March 1, 2002; 30(5): 1114 - 1123.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
V. M. Richon and J. P. O'Brien
Histone Deacetylase Inhibitors: A New Class of Potential Therapeutic Agents for Cancer Treatment : Commentary re: V. Sandor et al., Phase I Trial of the Histone Deacetylase Inhibitor, Depsipeptide (FR901228, NSC 630176), in Patients with Refractory Neoplasms. Clin. Cancer Res., 8: 718-728, 2002.
Clin. Cancer Res., March 1, 2002; 8(3): 662 - 664.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. D. Fischer, R. Cai, U. Bhatia, F. A. M. Asselbergs, C. Song, R. Terry, N. Trogani, R. Widmer, P. Atadja, and D. Cohen
Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10
J. Biol. Chem., February 15, 2002; 277(8): 6656 - 6666.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.